EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
ramusmedical
news

This form of brain training may help treat severe schizophrenia

New research has revealed that targeted cognitive training can successfully reduce cognitive impairment in treatment-resistant schizophrenia. Altering certain neura...
20 December 2018 news
Continue Reading →
Europe

WU biomedical engineer makes a significant step toward precision medicine

In 2015, then President Barack Obama launched a precision medicine initiative, saying that its promise was "delivering the right treatments, at the right time, every ...
20 December 2018 Europe | news | North America | Regional News
Continue Reading →
Europe

Sutimlimab shows promise for hard-to-treat, rare blood disorder

In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare c...
20 December 2018 Europe | news | North America | Regional News
Continue Reading →
Europe

First line immunotherapy combination fails to improve overall survival in lung cancer

First line immunotherapy with durvalumab or the combination of durvalumab and tremelimumab does not improve overall survival in unselected patients with lung cancer, ...
20 December 2018 Europe | news | Regional News
Continue Reading →
news

XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study

Biomarkers Predict Significantly Higher Rates of Treatment Response to Bermekimab in Advanced Cancer Patients AUSTIN, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- XBiotec...
20 December 2018 news | North America | Regional News
Continue Reading →
Europe

Minoryx Therapeutics announces early completion of patient randomization in the ADVANCE trial: a phase 2/3 clinical study of MIN-102 in X-ALD patients

Mataró, Barcelona, Spain, December 12, 2018 – Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that i...
20 December 2018 Europe | news | Regional News
Continue Reading →
Europe

Shivom Partners With Lifebit To Power AI-Analysis of DNA Data For Clinical Trials

Blockchain genomics pioneer and AI data analysis firm will provide pharmaceutical organisations and life science users with comprehensive reporting through a library ...
20 December 2018 Europe | news | Regional News
Continue Reading →
Europe

Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial

Stockholm – December 18, 2018. On December 17 Asarina Pharma’s Scientific Advisory Board (SAB) gave its full backing to the company’s upcoming trial of a new prevent...
20 December 2018 Europe | news | Regional News
Continue Reading →
news

PCI Continues to Invest According to Market Demand as Specialist 2-8°C Cold Chain Capabilities Become Operational at Hay-on-Wye, UK Site

Hay-on-Wye Center of Excellence increases capacity for onsite 2-8°C Cold Chain storage. Philadelphia, USA – December 10, 2018 PCI Pharma Services (PCI), full-service...
10 December 2018 news | North America | Regional News
Continue Reading →
Australasia

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commer...
7 December 2018 Australasia | news | North America | Regional News
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte